Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page
- Check6 days agoChange DetectedThe study record’s update log was modified to add August 2026 entries and October/December 2026 entries while removing earlier dates, indicating administrative maintenance of the record rather than substantive content changes.SummaryDifference0.3%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page shows a revision update from v3.6.4 to v3.6.5, signaling a small page or backend update. This revision does not appear to alter the study details or data presented on the page.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page shows a revision string updated from v3.6.3 to v3.6.4, indicating an underlying site update rather than a change to the study data or text.SummaryDifference0.1%

- Check57 days agoChange DetectedThe revision tag was updated from v3.6.2 to v3.6.3, reflecting a behind-the-scenes platform update to the page. This indicates a minor software release rather than changes to the study content.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2, indicating a small site update. No study information or content is affected.SummaryDifference0.1%

- Check79 days agoChange DetectedThe study page now includes an explicit note that recruitment is closed to participants, clarifying current enrollment status. In addition, header formatting for Intervention/Treatment is reformatted and new help/navigation items such as How to Read a Study Record, Common Questions, How to Join a Study, and a Revision note (v3.6.0) were added.SummaryDifference0.4%

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.